Avid Bioservices Inc (CDMO)

[hutschi]

UNM begins testing of new cancer-fighting drug

The University of New Mexico Comprehensive Cancer Center successfully completed the first in-human testing of a promising new cancer drug called BXQ-350 that is meant to target solid malignant tumors.

Dr. Olivier Rixe has been involved in the development of BXQ-350 from the early stages of its conception and is the director of the clinical trial at UNM.

“You have a lot of steps with the (U.S. Food and Drug Administration),” he said. “It’s almost been 10 years from the initial concept to the first patients treated.”

The drug works by targeting a protein called phosphatidylserine, also known as PS, that is usually present in the inner cell membrane and plays a key role in cell signaling.

Rixe said in contrast to healthy cells, the PS protein is expressed on the outer membrane of cancerous cells......


http://www.dailylobo.com/article/2017/10/new-cancer-drug